SCHEDULE: Millennium Management Discloses 1.4% Passive Stake in Oaktree Acquisition Corp. III Life Sciences

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has disclosed a 1.4% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences, holding 277,689 Class A Ordinary Shares.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander collectively reported beneficial ownership of 277,689 Class A Ordinary Shares of Oaktree Acquisition Corp. III Life Sciences.
• This ownership represents 1.4% of the Class A Ordinary Shares outstanding.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment.
• The shares are held with shared voting power and shared dispositive power by the reporting persons.
• The acquisition of shares was not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of a passive ownership stake, providing factual information without indicating positive or negative performance or strategic shifts for the issuer.

Future Outlook

No forward-looking statements or guidance are provided in this ownership disclosure.

Industry Context

Oaktree Acquisition Corp. III Life Sciences operates as a Special Purpose Acquisition Company (SPAC) focused on the life sciences sector. The filing indicates a standard passive investment by Millennium Management, a prominent hedge fund, which is a common occurrence for institutional investors in publicly traded companies, including SPACs.

Comparison to Industry Standards

• The 1.4% beneficial ownership stake is typical for a passive investment by a large institutional investor like Millennium Management, falling well below the 5% threshold that would typically trigger more active reporting or influence under Schedule 13D.

Stakeholder Impact

• Shareholders: Provides transparency regarding the beneficial ownership stake held by a significant institutional investor.

Key Dates

Keywords

Oaktree Acquisition Corp. III Life Sciences, Millennium Management, Schedule 13G, Class A Ordinary Shares, SPAC, Life Sciences, Investment, Shareholding, Passive Investment